Charles Bonnet syndrome. Case report and subject revision.

Authors

  • Félix Alberto Pérez Estrada
  • Pedro Omar Betancourt Companioni
  • Sara Estela Romeu Yunaka
  • Eduardo Pérez Román
  • Haydée Román González

Abstract

The case of 77 years feminine patient appears, widow, coming from urban area, with hypertension antecedents, having regular treatment with enalapril 20 mg. everyday, with secondary visual deficit to age-related macular degeneration (ARMD), with progressive loss of visual acuity, she presented complex visual hallucinations in three years of evolution and after being studied by Psychiatry, Ophtalmology and Internal Medicine it was established the diagnosis of Charles Bonnet syndrome. This entity tends to be subdiagnosed in the scope of the health, given to its peculiarity and ignorance on the part of the medical personnel. It shows the main clinical characteristics of the syndrome, physiopathology, risk factors, diagnosis and treatment

Downloads

Download data is not yet available.

Author Biographies

Félix Alberto Pérez Estrada

Especialista de 2do Grado en Medicina Intensiva. Máster en Urgencias Médicas. Profesor Instructor.

Pedro Omar Betancourt Companioni

Especialista de 1er Grado en Imagenología. Profesor Auxiliar.

Sara Estela Romeu Yunaka

Especialista de 1er Grado en Oftalmología. Profesor Asistente.

Eduardo Pérez Román

Estudiante de 5to. Año de medicina, alumno ayudante de Medicina Intensiva.

Haydée Román González

Licenciada en Psicología.

References

Muñoz Cortés H, Vargas Rueda A. Síndrome de Charles Bonnet. Rev Colomb Psiquiatr [Internet]. 2007 [citado 5 Sep 2012]; 36(2): [aprox. 8 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034

Fernández A, Lichtshein B. The Charles Bonnet syndrome: a review. J Nerv Ment Dis. 1997; 185:195-199.

Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: Charles Bonnet syndrome. Surv Ophthalmol. 2003; 48:58-72.

Ffyche DH. Visual hallucinatory syndromes: past, present and future. Dialogues Clin Neurosci. 2007; 9(2): 173-89.

Terao T. Hallucinations in Alzheimer’s disease and Charles Bonnet syndrome. Am J Psychiatr. 2000; 157(12):62.

Chen J, Gómez M, Veit S, O’Dowd MA. Visual hallucinations in blind elderly woman: Charles Bonnet syndrome, an under recognized clinical condition. Gen Hosp Psychiatr. 1996;18:453-55.

Teunisse R. The CBS a large prospective study in the Netherlands. Br J Psych. 1995; 166:254-57.

Folstein M, Folstein S, MCHugh PR. Minimental State: a practical method for grading the cognitive state of the patients for the clinician. J Psychiatr Res. 1975; 12:189-98.

Tejedor JH. Alucinaciones visuales en el anciano. Med Clin. 2002; 118(9):353-6

Mewasingh LD, Kornreich C, Christiaens F, Christophe C, Dan B. Pediatric phantom vision (Charles Bonnet) syndrome. Pediatr Neurol. 2002; 26(2): 143-5

Tan CS, Sabel BA, Goh K-Y. Visual hallucinations during visual recovery after central retinal artery occlusion. Arch Neurol. 2006; 63: 598-600.

Pliskin NH, Kiolbasa TA, Towle VL, Pankow L, Ernest JT, Noronha A, et al. Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc. 1996; 44(9):1055-61.

Evers S, Eliger T. The clinical spectrum of musical hallucinations. J Neurol Sci. 2004; 227(1): 55-6.

González M, De Pablo J, Valdés M. Delirium, la confusión de los clínicos. Rev Méd Chil. 2003; 131: 1051-60

Santhouse AM, Howard RJ, ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000; 123: 2055-64

Ffytche D, Howard RJ. The perceptual consequences of visual loss: “positive” pathologics of vision. Brain. 1999; 122(7):1247-60.

Howard RJ. Visual hallucinatory syndromes and the anatomy of the visual. Brain. 2000; 123:2055-64.

Burke W. The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatr. 2002; 73(5): 535-41.

Shiraishi Y, Terao T, Ibi K, Nakamura J, Tawara A. Charles Bonnet syndrome and visual acuity the involvement of dynamic or acute sensory deprivation. Eur Arch Psychiatry Clin Neurosc. 2004; 254(6): 362-64.

Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry Clin Neurosci. 2000; 54(2): 157-62.

Teunisse RJ, Cruysberg JR, Hoefnagels WH, van't Hof MA, Verbeek AL, Zitman FG. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis. 1998; 186(3): 190-2.

Coletti MM, Milano E, Gasverde S, Gianelli M, Giordana MT. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci. 2005; 26: 168-70.

Siddiqui Z, Ramaswmay S, Petty R. Mirtazapine for Charles Bonnet syndrome. Can J Psychiatr. 2004; 49(11): 787-788

Eperjesi F, Akbarali N. Rehabilitation in Charles Bonnet syndrome: a review of treatment options. Clin Exp Optom. 2004; 87: 149-52

Rovner BW. The Charles Bonnet Syndrome: a review of recent research. Curr Opin Ophthaimol. 2006; 17: 275-277.

Downloads

Published

2013-12-19

How to Cite

1.
Pérez Estrada FA, Betancourt Companioni PO, Romeu Yunaka SE, Pérez Román E, Román González H. Charles Bonnet syndrome. Case report and subject revision. Mediciego [Internet]. 2013 Dec. 19 [cited 2024 Dec. 22];19(1). Available from: https://revmediciego.sld.cu/index.php/mediciego/article/view/261

Issue

Vol. 19 No. 1 (2013): Suplemento 1

Section

Original article

License

Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):

You are free to:

  1. Share — copy and redistribute the material in any medium or format
  2. Adapt — remix, transform, and build upon the material
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  1. Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. NonCommercial — You may not use the material for commercial purposes .
  3. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Notices:

You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .

No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Most read articles by the same author(s)